XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues    
Total Revenues $ 1,346.6 $ 1,253.3
Expenses    
Compensation and benefits 185.2 225.0
Technology 45.9 48.2
Professional fees and outside services 31.8 37.4
Amortization of purchased intangibles 58.4 60.6
Depreciation and amortization 33.5 37.6
Licensing and other fee agreements 80.9 64.7
Other 51.8 54.7
Total Expenses 487.5 528.2
Operating Income 859.1 725.1
Non-Operating Income (Expense)    
Investment income 73.1 30.9
Interest and other borrowing costs (42.5) (41.5)
Equity in net earnings of unconsolidated subsidiaries 73.3 56.2
Other non-operating income (expense) (46.7) (18.4)
Total Non-Operating Income (Expense) 57.2 27.2
Income before Income Taxes 916.3 752.3
Income tax provision 205.3 177.5
Net Income 711.0 574.8
Less: net (income) loss attributable to non-controlling interests 0.0 (0.4)
Net Income Attributable to CME Group 711.0 574.4
Net Income Attributable to Common Shareholders of CME Group $ 702.0 $ 574.4
Earnings per Share Attributable to Common Shareholders of CME Group:    
Basic (in dollars per share) $ 1.96 $ 1.60
Diluted (in dollars per share) $ 1.95 $ 1.60
Weighted Average Number of Common Shares:    
Basic (in shares) 358,609 358,147
Diluted (in shares) 359,180 358,817
Clearing and transaction fees [Member]    
Revenues    
Total Revenues $ 1,138.1 $ 1,007.0
Market data and information services    
Revenues    
Total Revenues 151.7 144.2
Other    
Revenues    
Total Revenues $ 56.8 $ 102.1